HER2+ esophageal carcinoma leptomeningeal metastases treated with intrathecal trastuzumab regimen
Materials & methods: We recently reported the largest trial of breast cancer patients with HER2 positive leptomeningeal metastases (LM) treated with trastuzumab. An additional treatment indication was explored as part of a single institution retrospective case series of HER2 positive esophageal aden...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis Group
2023-09-01
|
| Seri Bilgileri: | CNS Oncology |
| Konular: | |
| Online Erişim: | https://www.futuremedicine.com/doi/10.2217/cns-2022-0018 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|